List of Tables:

TABLE 1 MARKET SYNOPSIS
TABLE 2 LIST OF ASSUMPTIONS
TABLE 3 North America PROCEDURE NUMBERS, 2010-2016 (UNITS)
TABLE 4 North America PROCEDURE NUMBERS, 2017-2023 (UNITS)
TABLE 5 SOUTH AMERICA PROCEDURE NUMBERS, 2010-2016 (UNITS)
TABLE 6 SOUTH AMERICA PROCEDURE NUMBERS, 2017-2023 (UNITS)
TABLE 7 EUROPE PROCEDURE NUMBERS, 2010-2016 (UNITS)
TABLE 8 EUROPE PROCEDURE NUMBERS, 2017-2023 (UNITS)
TABLE 9 ASIA PACIFIC PROCEDURE NUMBERS, 2010-2016 (UNITS)
TABLE 10 ASIA PACIFIC PROCEDURE NUMBERS, 2017-2023 (UNITS)
TABLE 11 THE MIDDLE EAST PROCEDURE NUMBERS, 2010-2016 (UNITS)
TABLE 12 THE MIDDLE EAST PROCEDURE NUMBERS, 2017-2023 (UNITS)
TABLE 13 AFRICA PROCEDURE NUMBERS, 2010-2016 (UNITS)
TABLE 14 AFRICA PROCEDURE NUMBERS, 2017-2023 (UNITS)
TABLE 15 GLOBAL AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (USD Million)
TABLE 16 GLOBAL AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (USD Million)
TABLE 17 GLOBAL AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (PROCEDURE)
TABLE 18 GLOBAL AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (PROCEDURE)
TABLE 19 GLOBAL AVASCULAR NECROSIS MARKET FOR NON-TRAUMA RELATED AVASCULAR NECROSIS OR OSTEONECROSIS, BY REGION, 2010-2017 (USD Million)
TABLE 20 GLOBAL AVASCULAR NECROSIS MARKET FOR NON-TRAUMA RELATED AVASCULAR NECROSIS OR OSTEONECROSIS, BY REGION, 2018-2024 (USD Million)
TABLE 21 GLOBAL AVASCULAR NECROSIS MARKET, BY AGE GROUP, 2010-2017 (USD Million)
TABLE 22 GLOBAL AVASCULAR NECROSIS MARKET, BY AGE GROUP,2018-2024 (USD Million)
TABLE 23 GLOBAL AVASCULAR NECROSIS MARKET, BY AGE GROUP, 2010-2017 (PROCEDURE)
TABLE 24 GLOBAL AVASCULAR NECROSIS MARKET, BY AGE GROUP,2018-2024 (PROCEDURE)
TABLE 25 GLOBAL AVASCULAR NECROSIS MARKET FOR THIRD DECADE, BY REGION 2010-2017 (USD Million)
TABLE 26 GLOBAL AVASCULAR NECROSIS MARKET FOR THIRD DECADE, BY REGION, 2018-2024 (USD Million)
TABLE 27 GLOBAL AVASCULAR NECROSIS MARKET FOR FIFTH DECADE, BY REGION, 2010-2017 (USD Million)
TABLE 28 GLOBAL AVASCULAR NECROSIS MARKET FOR FIFTH DECADE, BY REGION, 2018-2024 (USD Million)
TABLE 29 GLOBAL AVASCULAR NECROSIS MARKET, BY CAUSES, 2010-2017 (USD Million)
TABLE 30 GLOBAL AVASCULAR NECROSIS MARKET, BY CAUSES, 2018-2024 (USD Million)
TABLE 31 GLOBAL AVASCULAR NECROSIS MARKET, BY CAUSES, 2010-2017 (PROCEDURE)
TABLE 32 GLOBAL AVASCULAR NECROSIS MARKET, BY CAUSES, 2018-2024 (PROCEDURE)
TABLE 33 GLOBAL AVASCULAR NECROSIS MARKET FOR CAISSON DISEASE, BY REGION, 2010-2017 (USD Million)
TABLE 34 GLOBAL AVASCULAR NECROSIS MARKET FOR CAISSON DISEASE, BY REGION, 2018-2024 (USD Million)
TABLE 35 GLOBAL AVASCULAR NECROSIS MARKET FOR SICKLE CELL ANAEMIA, BY REGION, 2010-2017 (USD Million)
TABLE 36 GLOBAL AVASCULAR NECROSIS MARKET FOR SICKLE CELL ANEMIA, BY REGION, 2018-2024 (USD Million)
TABLE 37 GLOBAL AVASCULAR NECROSIS MARKET FOR STEROID ABUSE, BY REGION, 2010-2017 (USD Million)
TABLE 38 GLOBAL AVASCULAR NECROSIS MARKET FOR STEROID ABUSE, BY REGION, 2018-2024 (USD Million)
TABLE 39 GLOBAL AVASCULAR NECROSIS MARKET FOR ALCOHOL ABUSE, BY REGION, 2010-2017 (USD Million)
TABLE 40 GLOBAL AVASCULAR NECROSIS MARKET FOR ALCOHOL ABUSE, BY REGION, 2018-2024 (USD Million)
TABLE 41 GLOBAL AVASCULAR NECROSIS MARKET FOR TRAUMA RELATED AVASCULAR NECROSIS OR OSTEONECROSIS, BY REGION, 2010-2017 (USD Million)
TABLE 42 GLOBAL AVASCULAR NECROSIS MARKET FOR TRAUMA RELATED AVASCULAR NECROSIS OR OSTEONECROSIS, BY REGION, 2018-2024 (USD Million)
TABLE 43 GLOBAL AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (USD Million)
TABLE 44 GLOBAL AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (USD Million)
TABLE 45 GLOBAL AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (PROCEDURE)
TABLE 46 GLOBAL AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (PROCEDURE)
TABLE 47 GLOBAL AVASCULAR NECROSIS MARKET FOR HIP BONE, BY REGION, 2010-2017 (USD Million)
TABLE 48 GLOBAL AVASCULAR NECROSIS MARKET, FOR HIP BONE, BY REGION, 2018-2024 (USD Million)
TABLE 49 GLOBAL AVASCULAR NECROSIS MARKET FOR KNEE, BY REGION, 2010-2017 (USD Million)
TABLE 50 GLOBAL AVASCULAR NECROSIS MARKET FOR KNEE, BY REGION, 2018-2024 (USD Million)
TABLE 51 GLOBAL AVASCULAR NECROSIS MARKET FOR SHOULDER, BY REGION, 2010-2017 (USD Million)
TABLE 52 GLOBAL AVASCULAR NECROSIS MARKET FOR SHOULDER, BY REGION, 2018-2024 (USD Million)
TABLE 53 GLOBAL AVASCULAR NECROSIS MARKET BY DIAGNOSIS, 2010-2017 (USD Million)
TABLE 54 GLOBAL AVASCULAR NECROSIS MARKET BY DIAGNOSIS, 2018-2024 (USD Million)
TABLE 55 GLOBAL AVASCULAR NECROSIS MARKET BY DIAGNOSIS, 2010-2017 (PROCEDURE)
TABLE 56 GLOBAL AVASCULAR NECROSIS MARKET BY DIAGNOSIS, 2018-2024 (PROCEDURE)
TABLE 57 GLOBAL AVASCULAR NECROSIS MARKET FOR IMAGING, BY REGION, 2010-2017 (USD Million)
TABLE 58 GLOBAL AVASCULAR NECROSIS MARKET FOR IMAGING, BY REGION, 2018-2024 (USD Million)
TABLE 59 GLOBAL AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (PROCEDURE)
TABLE 60 GLOBAL AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (PROCEDURE)
TABLE 61 GLOBAL AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (USD Million)
TABLE 62 GLOBAL AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (USD Million)
TABLE 63 GLOBAL AVASCULAR NECROSIS MARKET FOR X-RAY, BY REGION, 2010-2017 (USD Million)
TABLE 64 GLOBAL AVASCULAR NECROSIS MARKET FOR X-RAY , BY REGION, 2018-2024 (USD Million)
TABLE 65 GLOBAL AVASCULAR NECROSIS MARKET FOR CT SCAN, BY REGION, 2010-2017 (USD Million)
TABLE 66 GLOBAL AVASCULAR NECROSIS MARKET FOR CT SCAN, BY REGION, 2018-2024 (USD Million)
TABLE 67 GLOBAL AVASCULAR NECROSIS MARKET FOR MRI, BY REGION, 2010-2017 (USD Million)
TABLE 68 GLOBAL AVASCULAR NECROSIS MARKET FOR MRI, BY REGION, 2018-2024 (USD Million)
TABLE 69 GLOBAL AVASCULAR NECROSIS MARKET FOR PET, BY REGION, 2010-2017 (USD Million)
TABLE 70 GLOBAL AVASCULAR NECROSIS MARKET FOR PET, BY REGION, 2018-2024 (USD Million)
TABLE 71 GLOBAL AVASCULAR NECROSIS MARKET FOR BIOPSY, BY REGION, 2010-2017 (USD Million)
TABLE 72 GLOBAL AVASCULAR NECROSIS MARKET FOR BIOPSY, BY REGION, 2018-2024 (USD Million)
TABLE 73 GLOBAL AVASCULAR NECROSIS MARKET BY TREATMENT, 2010-2017 (USD Million)
TABLE 74 GLOBAL AVASCULAR NECROSIS MARKET BY TREATMENT, 2018-2024 (USD Million)
TABLE 75 GLOBAL AVASCULAR NECROSIS MARKET BY TREATMENT, 2010-2017 (PROCEDURE)
TABLE 76 GLOBAL AVASCULAR NECROSIS MARKET BY TREATMENT, 2018-2024 (PROCEDURE)
TABLE 77 GLOBAL AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, BY REGION, 2010-2017 (USD Million)
TABLE 78 GLOBAL AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, BY REGION, 2018-2024 (USD Million)
TABLE 79 GLOBAL AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2010-2017 (USD Million)
TABLE 80 GLOBAL AVASCULAR NECROSIS MARKET FOR MEDICATION BY NSAIDS, 2018-2024 (USD Million)
TABLE 81 GLOBAL AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2010-2017 (USD Million)
TABLE 82 GLOBAL AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2018-2024 (USD Million)
TABLE 83 GLOBAL AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2010-2017 (USD Million)
TABLE 84 GLOBAL AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2018-2024 (USD Million)
TABLE 85 GLOBAL AVASCULAR NECROSIS MARKET FOR ELECTRICAL STIMULATION, BY REGION, 2010-2017 (USD Million)
TABLE 86 GLOBAL AVASCULAR NECROSIS MARKET FOR ELECTRICAL STIMULATION, BY REGION, 2018-2024 (USD Million)
TABLE 87 GLOBAL AVASCULAR NECROSIS MARKET FOR GENE THERAPY, BY REGION, 2010-2017 (USD Million)
TABLE 88 GLOBAL AVASCULAR NECROSIS MARKET FOR GENE THERAPY, BY REGION, 2018-2024 (USD Million)
TABLE 89 GLOBAL AVASCULAR NECROSIS MARKET FOR GENE THERAPY, BY REGION, 2010-2017 (USD Million)
TABLE 90 GLOBAL AVASCULAR NECROSIS MARKET FOR GENE THERAPY, BY REGION, 2018-2024 (USD Million)
TABLE 91 GLOBAL AVASCULAR NECROSIS MARKET FOR SURGERY, BTY TYPE, 2010-2017 (USD Million)
TABLE 92 GLOBAL AVASCULAR NECROSIS MARKET FOR SURGERY, BTY TYPE, 2018-2024 (USD Million)
TABLE 93 GLOBAL AVASCULAR NECROSIS MARKET FOR SURGERY, BY TYPE, 2010-2017 (PROCEDURE)
TABLE 94 GLOBAL AVASCULAR NECROSIS MARKET FOR SURGERY, BY TYPE, 2018-2024 (PROCEDURE)
TABLE 95 GLOBAL AVASCULAR NECROSIS MARKET FOR CORE DECOMPRESSION, BY REGION, 2010-2017 (USD Million)
TABLE 96 GLOBAL AVASCULAR NECROSIS MARKET FOR CORE DECOMPRESSION , BY REGION, 2018-2024 (USD Million)
TABLE 97 GLOBAL AVASCULAR NECROSIS MARKET FOR OSTEOTOMY , BY REGION, 2010-2017 (USD Million)
TABLE 98 GLOBAL AVASCULAR NECROSIS MARKET FOR OSTEOTOMY, BY REGION, 2018-2024 (USD Million)
TABLE 99 GLOBAL AVASCULAR NECROSIS MARKET FOR BONE GRAFT, BY REGION, 2010-2017 (USD Million)
TABLE 100 GLOBAL AVASCULAR NECROSIS MARKET FOR BONE GRAFT, BY REGION, 2018-2024 (USD Million)
TABLE 101 GLOBAL AVASCULAR NECROSIS MARKET FOR ARTHOPLASTY, BY REGION, 2010-2017 (USD Million)
TABLE 102 GLOBAL AVASCULAR NECROSIS MARKET FOR ARTHOPLASTY, BY REGION, 2018-2024 (USD Million)
TABLE 103 GLOBAL AVASCULAR NECROSIS MARKET FOR END USER, BY REGION, 2010-2017 (USD Million)
TABLE 104 GLOBAL AVASCULAR NECROSIS MARKET FOR END USER, BY REGION, 2018-2024 (USD Million)
TABLE 105 GLOBAL AVASCULAR NECROSIS MARKET FOR END USER, BY REGION, 2010-2017 (PROCEDURE)
TABLE 106 GLOBAL AVASCULAR NECROSIS MARKET FOR END USER, BY REGION, 2018-2024 (PROCEDURE)
TABLE 107 GLOBAL AVASCULAR NECROSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2010-2017 (USD Million)
TABLE 108 GLOBAL AVASCULAR NECROSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD Million)
TABLE 109 GLOBAL AVASCULAR NECROSIS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2010-2017 (USD Million)
TABLE 110 GLOBAL AVASCULAR NECROSIS MARKET FOR DIAGNOSTIC CENTERS , BY REGION, 2018-2024 (USD Million)
TABLE 111 GLOBAL AVASCULAR NECROSIS MARKET FOR AMBULATORY SURGICAL CENTERS , BY REGION, 2010 2017 (USD Million)
TABLE 112 GLOBAL AVASCULAR NECROSIS MARKET FOR AMBULATORY SURGICAL CENTERS , BY REGION, 2018-2024 (USD Million)
TABLE 113 GLOBAL AVASCULAR NECROSIS MARKET, BY REGION, 2010-2017 (USD Million)
TABLE 114 GLOBAL AVASCULAR NECROSIS MARKET, BY REGION, 2018-2024 (USD Million)
TABLE 115 GLOBAL AVASCULAR NECROSIS MARKET, BY REGION, 2010-2017 (PROCEDURE)
TABLE 116 GLOBAL AVASCULAR NECROSIS MARKET, BY REGION, 2018-2024 (PROCEDURE)
TABLE 117 AMERICAS AVASCULAR NECROSIS MARKET, BY REGION, 2010-2017 (USD Million)
TABLE 118 AMERICAS AVASCULAR NECROSIS MARKET, BY REGION, 2018-2024 (USD Million)
TABLE 119 AMERICAS AVASCULAR NECROSIS MARKET, BY REGION, 2010-2017 (PROCEDURE)
TABLE 120 AMERICAS AVASCULAR NECROSIS MARKET, BY REGION, 2018-2024 (PROCEDURE)
TABLE 121 AMERICAS AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (USD Million)
TABLE 122 AMERICAS AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (USD Million)
TABLE 123 AMERICAS AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (PROCEDURE)
TABLE 124 AMERICAS AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (PROCEDURE)
TABLE 125 AMERICAS NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (USD Million)
TABLE 126 AMERICAS NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (USD Million)
TABLE 127 AMERICAS NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (PROCEDURE)
TABLE 128 AMERICAS NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (PROCEDURE)
TABLE 129 AMERICAS NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (USD Million)
TABLE 130 AMERICAS NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (USD Million)
TABLE 131 AMERICAS NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (PROCEDURE)
TABLE 132 AMERICAS NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (PROCEDURE)
TABLE 133 AMERICAS AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (USD Million)
TABLE 134 AMERICAS AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (USD Million)
TABLE 135 AMERICAS AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (PROCEDURE)
TABLE 136 AMERICAS AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (PROCEDURE)
TABLE 137 AMERICAS AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (USD Million)
TABLE 138 AMERICAS AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (USD Million)
TABLE 139 AMERICAS AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (PROCEDURE)
TABLE 140 AMERICAS AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (PROCEDURE)
TABLE 141 AMERICAS AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (USD Million)
TABLE 142 AMERICAS AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (USD Million)
TABLE 143 AMERICAS AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (PROCEDURE)
TABLE 144 AMERICAS AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (PROCEDURE)
TABLE 145 AMERICAS AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (USD Million)
TABLE 146 AMERICAS AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (USD Million)
TABLE 147 AMERICAS AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (PROCEDURE)
TABLE 148 AMERICAS AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (PROCEDURE)
TABLE 149 AMERICAS AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2010-2017 (USD Million)
TABLE 150 AMERICAS AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2018-2024 (USD Million)
TABLE 151 AMERICAS AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2010-2017 (USD Million)
TABLE 152 AMERICAS AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2018-2024 (USD Million)
TABLE 153 AMERICAS AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2010-2017 (USD Million)
TABLE 154 AMERICAS AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2018-2024 (USD Million)
TABLE 155 AMERICAS AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2010-2017 (USD Million)
TABLE 156 AMERICAS AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2018-2024 (USD Million)
TABLE 157 AMERICAS AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (USD Million)
TABLE 158 AMERICAS AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (USD Million)
TABLE 159 AMERICAS AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (PROCEDURE)
TABLE 160 AMERICAS AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (PROCEDURE)
TABLE 161 AMERICAS AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (USD Million)
TABLE 162 AMERICAS AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (USD Million)
TABLE 163 AMERICAS AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (PROCEDURE)
TABLE 164 AMERICAS AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (PROCEDURE)
TABLE 165 North America AVASCULAR NECROSIS MARKET, BY REGION, 2010-2017 (USD Million)
TABLE 166 North America AVASCULAR NECROSIS MARKET, BY REGION, 2018-2024 (USD Million)
TABLE 167 North America AVASCULAR NECROSIS MARKET, BY REGION, 2010-2017 (PROCEDURE)
TABLE 168 North America AVASCULAR NECROSIS MARKET, BY REGION, 2018-2024 (PROCEDURE)
TABLE 169 North America AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (USD Million)
TABLE 170 North America AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (USD Million)
TABLE 171 North America AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (PROCEDURE)
TABLE 172 North America AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (PROCEDURE)
TABLE 173 North America NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (USD Million)
TABLE 174 North America NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (USD Million)
TABLE 175 North America NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (PROCEDURE)
TABLE 176 North America NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (PROCEDURE)
TABLE 177 North America NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (USD Million)
TABLE 178 North America NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (USD Million)
TABLE 179 North America NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (PROCEDURE)
TABLE 180 North America NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (PROCEDURE)
TABLE 181 North America AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (USD Million)
TABLE 182 North America AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (USD Million)
TABLE 183 North America AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (PROCEDURE)
TABLE 184 North America AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (PROCEDURE)
TABLE 185 North America AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (USD Million)
TABLE 186 North America AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (USD Million)
TABLE 187 North America AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (PROCEDURE)
TABLE 188 North America AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (PROCEDURE)
TABLE 189 North America AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (USD Million)
TABLE 190 North America AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (USD Million)
TABLE 191 North America AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (PROCEDURE)
TABLE 192 North America AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (PROCEDURE)
TABLE 193 North America AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (USD Million)
TABLE 194 North America AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (USD Million)
TABLE 195 North America AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (PROCEDURE)
TABLE 196 North America AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (PROCEDURE)
TABLE 197 North America AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2010-2017 (USD Million)
TABLE 198 North America AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2018-2024 (USD Million)
TABLE 199 North America AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2010-2017 (USD Million)
TABLE 200 North America AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2018-2024 (USD Million)
TABLE 201 North America AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2010-2017 (USD Million)
TABLE 202 North America AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2018-2024 (USD Million)
TABLE 203 North America AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2010-2017 (USD Million)
TABLE 204 North America AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2018-2024 (USD Million)
TABLE 205 North America AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (USD Million)
TABLE 206 North America AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (USD Million)
TABLE 207 North America AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (PROCEDURE)
TABLE 208 North America AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (PROCEDURE)
TABLE 209 North America AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (USD Million)
TABLE 210 North America AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (PROCEDURE)
TABLE 211 North America AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (PROCEDURE)
TABLE 212 North America AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (USD Million)
TABLE 213 U.S. AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (USD Million)
TABLE 214 U.S. AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (USD Million)
TABLE 215 U.S. AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (PROCEDURE)
TABLE 216 U.S. AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (PROCEDURE)
TABLE 217 U.S. NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (USD Million)
TABLE 218 U.S. NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (USD Million)
TABLE 219 U.S. NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (PROCEDURE)
TABLE 220 U.S. NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (PROCEDURE)
TABLE 221 U.S. NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (USD Million)
TABLE 222 U.S. NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (USD Million)
TABLE 223 .S. NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (PROCEDURE)
TABLE 224 U.S. NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (PROCEDURE)
TABLE 225 U.S. AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (USD Million)
TABLE 226 U.S. AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (USD Million)
TABLE 227 U.S. AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (PROCEDURE)
TABLE 228 U.S. AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (PROCEDURE)
TABLE 229 U.S. AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (USD Million)
TABLE 230 U.S. AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (USD Million)
TABLE 231 U.S. AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (PROCEDURE)
TABLE 232 U.S. AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (PROCEDURE)
TABLE 233 U.S. AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (USD Million)
TABLE 234 U.S. AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (USD Million)
TABLE 235 U.S. AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (PROCEDURE)
TABLE 236 U.S. AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (PROCEDURE)
TABLE 237 U.S. AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (USD Million)
TABLE 238 U.S. AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (USD Million)
TABLE 239 U.S. AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (PROCEDURE)
TABLE 240 U.S. AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (PROCEDURE)
TABLE 241 U.S. AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2010-2017 (USD Million)
TABLE 242 U.S. AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2018-2024 (USD Million)
TABLE 243 U.S. AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2010-2017 (USD Million)
TABLE 244 U.S. AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2018-2024 (USD Million)
TABLE 245 U.S. AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2010-2017 (USD Million)
TABLE 246 U.S. AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2018-2024 (USD Million)
TABLE 247 U.S. AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2010-2017 (USD Million)
TABLE 248 U.S. AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2018-2024 (USD Million)
TABLE 249 U.S. AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (USD Million)
TABLE 250 U.S. AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (USD Million)
TABLE 251 .S. AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (PROCEDURE)
TABLE 252 U.S. AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (PROCEDURE)
TABLE 253 U.S. AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (USD Million)
TABLE 254 U.S. AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (USD Million)
TABLE 255 U.S. AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (PROCEDURE)
TABLE 256 U.S. AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (PROCEDURE)
TABLE 257 CANADA AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (USD Million)
TABLE 258 CANADA AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (USD Million)
TABLE 259 CANADA AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (PROCEDURE)
TABLE 260 CANADA AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (PROCEDURE)
TABLE 261 CANADA NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (USD Million)
TABLE 262 CANADA NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (USD Million)
TABLE 263 CANADA NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (PROCEDURE)
TABLE 264 CANADA NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (PROCEDURE)
TABLE 265 CANADA NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (USD Million)
TABLE 266 CANADA NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (USD Million)
TABLE 267 CANADA NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (PROCEDURE)
TABLE 268 CANADA NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (PROCEDURE)
TABLE 269 CANADA AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (USD Million)
TABLE 270 CANADA AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (USD Million)
TABLE 271 CANADA AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (PROCEDURE)
TABLE 272 CANADA AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (PROCEDURE)
TABLE 273 CANADA AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (USD Million)
TABLE 274 CANADA AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (USD Million)
TABLE 275 CANADA AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (PROCEDURE)
TABLE 276 CANADA AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (PROCEDURE)
TABLE 277 CANADA AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (USD Million)
TABLE 278 CANADA AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (USD Million)
TABLE 279 CANADA AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (PROCEDURE)
TABLE 280 CANADA AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (PROCEDURE)
TABLE 281 CANADA AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (USD Million)
TABLE 282 CANADA AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (USD Million)
TABLE 283 CANADA AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (PROCEDURE)
TABLE 284 CANADA AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (PROCEDURE)
TABLE 285 CANADA AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2010-2017 (USD Million)
TABLE 286 CANADA AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2018-2024 (USD Million)
TABLE 287 CANADA AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2010-2017 (USD Million)
TABLE 288 CANADA AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2018-2024 (USD Million)
TABLE 289 CANADA AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2010-2017 (USD Million)
TABLE 290 CANADA AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2018-2024 (USD Million)
TABLE 291 CANADA AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2010-2017 (USD Million)
TABLE 292 CANADA AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2018-2024 (USD Million)
TABLE 293 CANADA AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (USD Million)
TABLE 294 CANADA AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (USD Million)
TABLE 295 CANADA AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (PROCEDURE)
TABLE 296 CANADA AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (PROCEDURE)
TABLE 297 CANADA AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (USD Million)
TABLE 298 CANADA AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (USD Million)
TABLE 299 CANADA AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (PROCEDURE)
TABLE 300 CANADA AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (PROCEDURE)
TABLE 301 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (USD Million)
TABLE 302 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (USD Million)
TABLE 303 . SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (PROCEDURE)
TABLE 304 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (PROCEDURE)
TABLE 305 SOUTH AMERICA NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (USD Million)
TABLE 306 SOUTH AMERICA NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (USD Million)
TABLE 307 SOUTH AMERICA NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (PROCEDURE)
TABLE 308 SOUTH AMERICA NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (PROCEDURE)
TABLE 309 SOUTH AMERICA NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (USD Million)
TABLE 310 SOUTH AMERICA NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (USD Million)
TABLE 311 SOUTH AMERICA NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2010-2017 (PROCEDURE)
TABLE 312 SOUTH AMERICA NON-TRAUMA RELATED AVN MARKET, BY CAUSES, 2018-2024 (PROCEDURE)
TABLE 313 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (USD Million)
TABLE 314 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (USD Million)
TABLE 315 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY SITE, 2010-2017 (PROCEDURE)
TABLE 316 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY SITE, 2018-2024 (PROCEDURE)
TABLE 317 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (USD Million)
TABLE 318 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (USD Million)
TABLE 319 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2010-2017 (PROCEDURE)
TABLE 320 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY DIAGNOSIS, 2018-2024 (PROCEDURE)
TABLE 321 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (USD Million)
TABLE 322 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (USD Million)
TABLE 323 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2010-2017 (PROCEDURE)
TABLE 324 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR DIAGNOSIS, BY IMAGING, 2018-2024 (PROCEDURE)
TABLE 325 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (USD Million)
TABLE 326 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (USD Million)
TABLE 327 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY TREATMENT, 2010-2017 (PROCEDURE)
TABLE 328 SOUTH AMERICA AVASCULAR NECROSIS MARKET, BY TREATMENT, 2018-2024 (PROCEDURE)
TABLE 329 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2010-2017 (USD Million)
TABLE 330 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR TREATMENT, BY MEDICATION, 2018-2024 (USD Million)
TABLE 331 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2010-2017 (USD Million)
TABLE 332 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR MEDICATION, BY NSAIDS, 2018-2024 (USD Million)
TABLE 333 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2010-2017 (USD Million)
TABLE 334 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR MEDICATION BY BISPHOSPHONATES, 2018-2024 (USD Million)
TABLE 335 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2010-2017 (USD Million)
TABLE 336 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR MEDICATION BY BLOOD THINNERS, 2018-2024 (USD Million)
TABLE 337 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (USD Million)
TABLE 338 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (USD Million)
TABLE 339 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2010-2017 (PROCEDURE)
TABLE 340 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR TREATMENT BY SURGERY, 2018-2024 (PROCEDURE)
TABLE 341 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (USD Million)
TABLE 342 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (USD Million)
TABLE 343 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR END USER, 2010-2017 (PROCEDURE)
TABLE 344 SOUTH AMERICA AVASCULAR NECROSIS MARKET FOR END USER, 2018-2024 (PROCEDURE)
TABLE 345 EUROPE AVASCULAR NECROSIS MARKET, BY REGION, 2010-2017 (USD Million)
TABLE 346 EUROPE AVASCULAR NECROSIS MARKET, BY REGION, 2018-2024 (USD Million)
TABLE 347 EUROPE AVASCULAR NECROSIS MARKET, BY REGION, 2010-2017 (PROCEDURE)
TABLE 348 EUROPE AVASCULAR NECROSIS MARKET, BY REGION, 2018-2024 (PROCEDURE)
TABLE 349 EUROPE AVASCULAR NECROSIS MARKET, BY COUNTRY, 2010-2017 (USD Million)
TABLE 350 EUROPE AVASCULAR NECROSIS MARKET, BY COUNTRY, 2018-2024 (USD Million)
TABLE 351 EUROPE AVASCULAR NECROSIS MARKET, BY COUNTRY, 2010-2017 (PROCEDURE)
TABLE 352 EUROPE AVASCULAR NECROSIS MARKET, BY COUNTRY, 2018-2024 (PROCEDURE)
TABLE 353 EUROPE AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (USD Million)
TABLE 354 EUROPE AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (USD Million)
TABLE 355 EUROPE AVASCULAR NECROSIS MARKET, BY TYPE, 2010-2017 (PROCEDURE)
TABLE 356 EUROPE AVASCULAR NECROSIS MARKET, BY TYPE, 2018-2024 (PROCEDURE)
TABLE 357 EUROPE NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (USD Million)
TABLE 358 EUROPE NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2018-2024 (USD Million)
TABLE 359 EUROPE NON-TRAUMA RELATED AVN MARKET, BY AGE GROUP, 2010-2017 (PROCEDURE)
TABLE 360 EUROPE

LIST OF FIGURE

List of Figures:

FIGURE 1 GLOBAL AVASCULAR NECROSIS MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 DRO OF GLOBAL AVASCULAR NECROSIS MARKET
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL AVASCULAR NECROSIS MARKET
FIGURE 6 SUPPLY CHAIN: AVASCULAR NECROSIS MARKET
FIGURE 7 GLOBAL AVASCULAR NECROSIS MARKET, BY TYPE, 2010, 2017, 2024 (USD Million)
FIGURE 8 GLOBAL AVASCULAR NECROSIS MARKET, BY SITE, 2010, 2017, 2024 (USD Million)
FIGURE 9 GLOBAL AVASCULAR NECROSIS MARKET, BY DIAGNOSIS 2010, 2017, 2024 (USD Million)
FIGURE 10 GLOBAL AVASCULAR NECROSIS MARKET, BY TREATMENT 2010, 2017, 2024 (USD MillionS)
FIGURE 11 GLOBAL AVASCULAR NECROSIS MARKET, BY END-USER 2010, 2017, 2024 (USD Million)
FIGURE 12 GLOBAL AVASCULAR NECROSIS MARKET, BY REGION, 2010, 2017 & 2024 (USD Million)
FIGURE 13 AMERICAS AVASCULAR NECROSIS MARKET, BY REGION, 2010, 2017 & 2023 (USD Million)
FIGURE 14 North America AVASCULAR NECROSIS MARKET, BY REGION, 2010, 2017, 2023 (USD Million)
FIGURE 15 EUROPE AVASCULAR NECROSIS MARKET, BY COUNTRY, 2010-2024 (USD Million)
FIGURE 16 ASIA PACIFIC AVASCULAR NECROSIS MARKET, BY COUNTRY, 2010-2024 (USD Million)
FIGURE 17 THE MIDDLE EAST & AFRICA AVASCULAR NECROSIS MARKET, BY COUNTRY, 2010-2024 (USD Million)
FIGURE 18 GLOBAL AVASCULAR NECROSIS MARKET, MARKET SHARE ANALYSIS 2017 (%)
FIGURE 19 GLOBAL AVASCULAR NECROSIS MARKET COMPETITIVE LANDSCAPE (%)